Clinical Trial Update: MF-4181 for the Reduction of Scars Secondary to Abdominoplasty or Laparoscopy/Laparotomy Gynecologic Procedures [Phase 2]

View source ↗

Summary

Phase 2 trial update for MF-4181 evaluating reduction of scars after abdominoplasty or gynecologic procedures; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scars

Drugs mentioned

• MF-4181

Snippet

Sponsor: Halscion, Inc. | Conditions: Scars | Phase 2 | Status: COMPLETED